Global Regulatory Strategy Toolkit
Multi-market regulatory strategy templates — pathway comparison, market sequencing, unified technical documentation, and authorized representative requirements across five major jurisdictions.
What You Get
Global Regulatory Pathway Comparison Matrix (FDA / EU MDR / Health Canada / TGA / PMDA)
Side-by-side comparison of regulatory requirements across the five major medical device markets. Covers classification systems, conformity assessment routes, submission types, review timelines, post-market obligations, and the key differences that affect global launch sequencing. Updated for current regulatory frameworks including QMSR, EU MDR, and MDSAP.
Global Market Entry Sequencing Framework
Strategic framework for determining the optimal order of regulatory submissions across markets. Covers the FDA-first vs CE-first debate, how MDSAP certification reduces audit burden across multiple jurisdictions, reciprocal recognition agreements, and the resource allocation model for small teams managing multi-market strategies.
Regulatory Intelligence Tracking Template
Ongoing intelligence tracking system for monitoring regulatory changes across target markets. Covers guidance document tracking, regulation update calendars, competent authority announcement monitoring, and the internal communication workflow for translating regulatory changes into QMS and submission impacts.
Global Technical File / Design Dossier Structure Template
Unified technical documentation structure that satisfies FDA 510k/PMA requirements, EU MDR Annex II, Health Canada Device License applications, and TGA ARTG submissions with minimal rework. Maps each section to jurisdiction-specific requirements and identifies where jurisdiction-specific addenda are required.
Market Access Timeline and Resource Planning Template
Project planning template for multi-market regulatory programs. Covers submission preparation timelines, review period estimates by jurisdiction, post-approval requirement milestones, and the resource model for regulatory affairs teams managing simultaneous multi-market submissions.
Authorized Representative and In-Country Contact Requirements Guide
Complete guide to authorized representative requirements across EU, UK, Switzerland, Australia, Canada, and Japan. Covers when an AR is required, what the AR is legally responsible for, selection criteria, contractual requirements, and the documentation that must flow between manufacturer and AR under each framework.
FAQ
Should I pursue FDA clearance or CE marking first?
It depends on your primary market and resources. FDA-first provides the strongest predicate for other markets. CE-first allows EU market entry with a faster timeline for certain device types. The sequencing framework covers the decision criteria for your specific situation.
Does MDSAP certification help with multiple markets?
Yes significantly. MDSAP covers FDA, Health Canada, TGA, ANVISA, and PMDA QMS audit requirements in a single audit. It eliminates redundant audits and is increasingly being accepted in lieu of separate QMS audits in participating markets.
What format are the documents?
All documents are editable Word and Excel templates ready for direct use and customization.
Ready to get started?
6 templates. Instant access. Multi-market regulatory strategy in one kit.
For informational purposes only. Not legal or regulatory advice. Legal